New BP Guidelines Could Benefit Many Americans With Kidney Disease medindia.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medindia.net Daily Mail and Mail on Sunday newspapers.
E-Mail
A recommendation for more intensive blood pressure management from an influential global nonprofit that publishes clinical practice guidelines in kidney disease could, if followed, benefit nearly 25 million Americans, according to an analysis led by researchers at the Johns Hopkins Bloomberg School of Public Health.
The new recommendation from Kidney Disease: Improving Global Outcomes, a global nonprofit that develops evidence-based clinical practice guidelines in kidney disease, is aimed at doctors to help them to reduce blood pressure for chronic kidney disease patients whose systolic blood pressure levels are over 120 mmHg. Blood pressure can be reduced using antihypertensive medications and lifestyle modifications. The analysis indicates that 69.5 percent of chronic kidney disease patients in the United States a total of 24.5 million people would meet that criterion.
This Viewpoint summarizes the pathophysiology and clinical features of atherosclerotic plaque erosion as an underlying mechanism of acute coronary syndromes (AC
February 09, 2021
Two additional randomized trials along with other analyses published since 2018 have helped to firm up formal guidance around antithrombotic therapy in patients with atrial fibrillation (AF) who are undergoing PCI.
Published yesterday, the updated North American consensus statement continues to recommend triple therapy with a direct oral anticoagulant (DOAC), a P2Y12 inhibitor, and aspirin during the peri-PCI period, after which the aspirin should be discontinued, according to experts from the United States and Canada.
That’s similar to what the group recommended in the last update published in 2018, but the publication of the AUGUSTUS and ENTRUST-AF PCI trials in the past few years “provides a lot of reassurance on the importance of an early discontinuation of aspirin in these patients,” lead author Dominick Angiolillo, MD, PhD (University of Florida College of Medicine – Jacksonville), told TCTMD.
Easy Health Options®
Are you going through the “cardiovascular change”?
Menopause is a time of distress due to the symptoms it brings. But few realize how much a woman’s risk for heart disease increases during this change. That’s because menopause isn’t just “the change” that marks the end of your menstrual cycle. It’s the time of life that also signals a change in cardiovascular health.
That change is probably a big part of the reason why heart disease is the number one killer of women and researchers are finally putting two and two together…
“Over the past 20 years, our knowledge of how the menopause transition might contribute to cardiovascular disease has been dramatically evolving,” said Samar R. El Khoudary, Ph.D., M.P.H., FAHA, chair of the statement writing committee and associate professor of epidemiology at the University of Pittsburgh’s Graduate School of Public Health and the Clinical and Translational Science Institute. “We have accumulat